Korean Drug Co. Ltd (014570) — Capital Reinvestment Ratio
Latest as of March 2026:
0.02x
Korean Drug Co. Ltd (014570) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.60 Billion) in capital expenditures (₩131.88 Million). See 014570 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.60 Billion
KRW
Capital Expenditures
₩131.88 Million
KRW
Data as of
Mar 2026
Most recent filing
Korean Drug Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Korean Drug Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Korean Drug Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Korean Drug Co. Ltd from 2014 to 2025. For live market cap and broader valuation context, see how much is Korean Drug Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩13.11 Billion | ₩475.05 Million | ▼ -83.1% |
| 2024 | 0.21x | ₩4.87 Billion | ₩1.04 Billion | ▼ -79.2% |
| 2022 | 1.03x | ₩5.91 Billion | ₩6.09 Billion | ▲ +691.9% |
| 2021 | 0.13x | ₩8.81 Billion | ₩1.15 Billion | ▲ +117.3% |
| 2020 | 0.06x | ₩12.33 Billion | ₩738.47 Million | ▼ -87.8% |
| 2019 | 0.49x | ₩6.21 Billion | ₩3.05 Billion | ▲ +118.8% |
| 2018 | 0.22x | ₩5.79 Billion | ₩1.30 Billion | ▼ -91.1% |
| 2017 | 2.53x | ₩447.20 Million | ₩1.13 Billion | ▲ +2077.4% |
| 2016 | 0.12x | ₩3.96 Billion | ₩460.84 Million | ▼ -18.8% |
| 2015 | 0.14x | ₩6.13 Billion | ₩878.05 Million | ▲ +18.7% |
| 2014 | 0.12x | ₩4.46 Billion | ₩538.19 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow